Characteristics of Patients with Anaphylaxis to European Hornet (Vespa crabro) Venom Compared to Anaphylaxis to Wasp (Vespula spp.) Venom in Southern Germany
International Archives of Allergy and Immunology · 2024
DOI: 10.1159/000542248 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Mattis Bertlich und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Anaphylaxis, Wasp Venoms, Wasps, Insect Bites and Stings. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Systemic hypersensitivity to hymenoptera species venom is the most common cause for anaphylaxis in adults. Due to similarities between hornet (Vespa crabro) and wasp (Vespula spp.) venom, patients with hornet venom anaphylaxis are often treated similarly to wasp-allergic patients. However, comparative data are scarce. This study aimed to analyze differences and similarities between these two groups.
Methods
A retrospective analysis with 42 patients with certain anaphylaxis to hornet venom was conducted. These were matched for age, gender, and CAP class with 42 patients with wasp venom anaphylaxis. Clinical outcomes and treatment adherence were compared.
Results
Patients with hornet venom anaphylaxis showed a significantly higher degree of anaphylaxis (21 vs. 9 patients with grade III/IV anaphylaxis, p < 0.001), despite similar tryptase levels (6.3 ± 8.3 vs. 5.1 ± 4.2) or presence of mastocytosis (2 vs. 3). These patients also showed significantly lower therapy adherence, resulting in fewer patients undergoing specific immune therapy (29 vs. 37, p = 0.030) or sting challenges (14 vs. 27, p = 0.046). Both groups showed high efficacy of specific immunotherapy with wasp venom extract.
Conclusion
Hornet stings induce more severe anaphylaxis, while patients with hornet venom allergies demonstrate lower treatment compliance, likely due to inadequate education. Specific immunotherapy with wasp venom extract remains effective for both.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany.
- Department of Dermatology, Venerology and Allergy, Heidelberg University, Heidelberg, Germany.
- Department of Dermatology, Thalkirchner Street Hospital, Munich Municipial Hospital Group, Munich, Germany.
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery, LMU University Hospital, LMU Munich, Munich, Germany.
- Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Zitieren
APA
Bertlich, M., Weber, F., Bertlich, I., Kendziora, B., Ruëff, F., Spiegel, J. L., French, L. E., & Oppel, E. (2024). Characteristics of Patients with Anaphylaxis to European Hornet (Vespa crabro) Venom Compared to Anaphylaxis to Wasp (Vespula spp.) Venom in Southern Germany. International Archives of Allergy and Immunology. https://doi.org/10.1159/000542248
Vancouver
Bertlich M, Weber F, Bertlich I, Kendziora B, Ruëff F, Spiegel JL, et al. Characteristics of Patients with Anaphylaxis to European Hornet (Vespa crabro) Venom Compared to Anaphylaxis to Wasp (Vespula spp.) Venom in Southern Germany. International Archives of Allergy and Immunology. 2024. doi:10.1159/000542248
BibTeX
@article{Bertlich2024,
author = {Bertlich, Mattis and Weber, Felix and Bertlich, Ines and Kendziora, Benjamin and Ruëff, Franziska and Spiegel, Jennifer L and French, Lars E and Oppel, Eva},
title = {Characteristics of Patients with Anaphylaxis to European Hornet (Vespa crabro) Venom Compared to Anaphylaxis to Wasp (Vespula spp.) Venom in Southern Germany},
journal = {International Archives of Allergy and Immunology},
year = {2024},
doi = {10.1159/000542248}
}
EUVIMED